EXFFERIDE® POWDER
Product Description
Kuhnil Pharm
-
KR
-
2023On CPHI since
-
250 - 499Employees
Company types
Primary activities
Categories
Specifications
Kuhnil Pharm
-
KR
-
2023On CPHI since
-
250 - 499Employees
Company types
Primary activities
More Products from Kuhnil Pharm (2)
-
Product ROSUMEGA®
(1) Mixed Hyperlipidemia
(2) Once daily, 2~4 soft capsules per day
(3) Dual Effect to reduce LCL-C and TG Level by patented technology* (3-layer coating)
(4) Combo’s additional decrease effect in residual cardiovascular risk & Omega-3’s multiple effects
(Lower... -
Product OMACOR® MINI CAPSULES
(1) Hypertriglyceridemia; Hyperlipidemia
(2) Once daily, 2g or up to 4g if necessary
(3) Ideal package for administration of ESC recommended strength of Omega-3 (ESC: European Society of Cardiology)
(4) Easy to swallow, patient-friendly dosage form
Kuhnil Pharm resources (1)
-
Brochure Kuhnil Introduction(LO)
Kuhnil Introduction for License-out- About Kuhnil
- Product Profile (LO)
- R&D Pipelines
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance